Efficacy of interferon β1a (Cinnovex) in relapsing-remitting multiple sclerosis patients

Abstract

Background : Multiple sclerosis is an inflammatory, chronic disease of the centre nervous system with demyelination in brain and spinal cord. Disability is evaluated by EDSS (Expanded Disability Scale Score). IFN β1a uses to prevent relapse rate and EDSS progression. The aim of this study was to evaluate efficacy of IFN β1a (Cinnovex) in relapsing- remitting multiple sclerosis patients.